Stay updated on Thykamine Safety & Efficacy in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Thykamine Safety & Efficacy in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Thykamine Safety & Efficacy in Atopic Dermatitis Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The completed Phase 2 Thykamine study record is displayed, including its design, eligibility criteria, treatment arms, outcome measures, locations, and study dates.
    Difference
    56%
    Check dated 2026-11-09T13:16:13.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T12:50:00.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    An NIH announcement says that federal agencies are transitioning to the term “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-26T14:08:35.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov error page footer shows revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-19T14:11:34.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T14:32:14.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with a minimal header, replacing the previous study content and study record details.
    Difference
    19%
    Check dated 2026-09-21T21:57:26.000Z thumbnail image

Stay in the know with updates to Thykamine Safety & Efficacy in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Thykamine Safety & Efficacy in Atopic Dermatitis Clinical Trial page.